During the first cycle of VIP standard dose chemotherapy the incidence of anaemia (Hb <12 g dl-1) reached 90% and about a quarter of patients dropped to Hb levels <10 g dl−1, indicating the impact of standard dose cisplatin based chemotherapy for the induction of anaemia. Here, GSTM1 is linked to anemia.